Global Particle Therapy Market Report By Type (Proton Therapy, Heavy lon Therapy), By Product & Service (Products (Cyclotrons, Synchrotrons, Synchrocyclotrons), Services), By System (Multi-Room Systems, Single-Room Systems), By Cancer Type (Pediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Head and Neck Cancer, Other Cancers), By Application (App Treatment Applications, Research Applications) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2023-2032

As per this study the Global Particle Therapy Market was valued USD 756.2 MN (by revenue) in 2022 and is anticipated to reach USD 1562.97 MN by 2030 with a CAGR of 9.5%.
 
Particle therapy is a type of cancer treatment by using external beam radiotherapy to kill cancerous cells. The beam of energized ionic particles is exposed and aimed at the damaged or carcinogenic cells. The particles damage DNA of the cell leading to its death. Particle therapy aims beam majorly on the tumor cell by sparing adjacent healthy cells and tissues. Hence is widely used to cure a various cancer types.
 
Market Dynamics
 
Growing count of population suffering from cancer has driven the demand for efficient cancer treatment. Rising adoption of advanced and efficient treatment and therapies to kill cancer cells is pushing the market demand. Also, growing usage of particle therapy for prostate cancer, head & neck cancer, lung cancer, etc. is boosting the market demand in healthcare facilities. In addition to this, rising R&D coupled with government support to boost development of advanced radiotherapy to cure hard to treat cancers is projected to raise the market growth in following years.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of particle therapy.
 
Market Segmentation
 
The broad particle therapy market has been sub-grouped into type, product & service, system and cancer type. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 

By Type

• Proton Therapy
• Heavy lon Therapy

By Product & Service

• Products (Cyclotrons, Synchrotrons, Synchrocyclotrons)
• Services

By System

• Multi-Room Systems
• Single-Room Systems

By Cancer Type

• Pediatric Cancer
• Prostate Cancer
• Lung Cancer
• Breast Cancer
• Head and Neck Cancer
• Other Cancers

By Application

• App Treatment Applications
• Research Applications

 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for particle therapy in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Global Particle Therapy Market Share by Region (Representative Graph)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the particle therapy market include IBA Worldwide (EU), Mevion Medical Systems (US), Varian Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Hitachi, Ltd. (Japan), Toshiba Medical Systems Corporation (Japan), and Provision Healthcare, LLC (US) among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.